MedPath

Charité Research Organisation GmbH

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:1
Completed:1

Trial Phases

2 Phases

Phase 1:2
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (66.7%)
Phase 2
1 (33.3%)

Safety and Preliminary Efficacy of the Combination of Niclosamide and Camostat

Phase 2
Terminated
Conditions
Covid19
Interventions
First Posted Date
2021-02-11
Last Posted Date
2021-12-09
Lead Sponsor
Charité Research Organisation GmbH
Target Recruit Count
4
Registration Number
NCT04750759
Locations
🇩🇪

Charité Research Organisation GmbH, Berlin, Germany

Safety and Pharmacokinetics of a Novel Niclosamide Solution in Combination With Camostat

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
Drug: Placebo
First Posted Date
2020-11-25
Last Posted Date
2021-11-29
Lead Sponsor
Charité Research Organisation GmbH
Target Recruit Count
28
Registration Number
NCT04644705
Locations
🇩🇪

Charité Research Organisation GmbH, Berlin, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.